Sign in
4

Changes in Ownership

NRX Pharmaceuticals, Inc. Filed Acc 0001415889-23-013137

Director bought 70,000 shares at $0.29 ($20,125)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hurvitz Chaim Director 2023-08-30 Purchase +70,000 $0.29 $20,125 570,000 D: show line 1 in the form
Open-market purchases · 70,000 sh · avg $0.29 · $20,125
Loading xslF345X05/form4-09112023_010907.xml…